Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® Sprinkle

Ads

You May Also Like

Argos Announces $1.5 Million Equity Investment by Lummy (Hong Kong), Ltd.

DURHAM, N.C., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...

Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe

NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...

NICE publishes advice on gammaCore for the treatment of cluster headache in the UK

Report contributors agreed gammaCore was highly innovative, may be more effective than standard of ...